From lab to lifesaver: the rise of CAR T-cell therapy in oncology

From lab to lifesaver: the rise of CAR T-cell therapy in oncology

Abstract Background Recently, cancer treatment paradigms have shifted dramatically with the advent of immunotherapies, particularly chimeric antigen receptor (CAR) T-cell therapy. Despite it is revolutionary positive outcomes in treating hematologic malignancies, challenges such as severe toxicities...

Full description

Saved in:
Bibliographic Details
Main Authors: Shriyash S. Jangavali, Pallavi B. Hangargekar, Balasaheb U. Gangthade, Shreya A. Jadhav, Ujwal A. Havelikar, Amol A. Joshi
Format: Article
Language:English
Published: SpringerOpen 2025-05-01
Series:Journal of the Egyptian National Cancer Institute
Subjects:
Chimeric antigen receptor
Oncology
Cancer immunotherapy
Cytotoxic release syndrome
CAR T-cell therapy
Online Access:https://doi.org/10.1186/s43046-025-00262-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s43046-025-00262-6

Similar Items